We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Wockhardt’s Generic Namenda Gets Tentative Approval
Wockhardt has received tentative FDA approval for 5- and 10-mg generic versions of Forest Laboratories’ Namenda tablets to treat moderate-to-severe Alzheimer’s disease and dementia.